Results 191 to 200 of about 51,881 (280)

Circulating prothymosin alpha and immunoglobulin G3 in acute rheumatic fever and rheumatic heart disease: A case-control study. [PDF]

Am Heart J Plus
Afshan G, Tsui N, Javed H, Kazmi T, Ndagire E, Pulle J, Huse K, Lias A, Talukder S, Lorenz N, McGregor R, Sable C, Beaton AZ, Moreland NJ, Okello E, Sadiq M, Parks T.   +16 more
europepmc   +2 more sources

Rapid screening for acute rheumatic fever using machine learning analysis of host tissue reactive antibodies. [PDF]

Sci Rep
Vo B, Rafeek RAM, Surve NZ, Karmarkar MG, Reeves B, Rishi G, Pandey M, Good MF, Ketheesan N.   +8 more
europepmc   +1 more source

Tissue‐retained needles in people who inject drugs: A systematic review of case reports and series on clinical presentations, complications and management

Addiction, Volume 121, Issue 6, Page 1381-1397, June 2026.
Abstract Background and aims Tissue‐retained needles from intravenous drug use can cause rare but severe complications, ranging from local to systemic infections to needle embolization. Due to the limited evidence and the lack of epidemiological studies on the issue, we systematically reviewed the literature focusing on case reports and case series on ...
Heidi Laukkala, Anna Nevalainen, Irina Rinta‐Kiikka, Samuel Heikkilä, Sisu Kiuru, Markku Sumanen, Otso Arponen, Olli Nevalainen   +7 more
wiley   +1 more source

A Retrospective Linked Data Analysis of Acute Rheumatic Fever and Rheumatic Heart Disease Diagnoses in Children Aged Under Five Years in Australia, 2001-2017. [PDF]

Aust J Rural Health
Cransberg J, Katzenellenbogen J, Remenyi B, Francia C, Murray K, Stacey I.   +5 more
europepmc   +1 more source

Tubulointerstitial nephritis and uveitis syndrome in children: What to keep an eye on

Acta Ophthalmologica, Volume 104, Issue 4, Page e443-e452, June 2026.
Abstract Purpose The purpose of this study was to determine the disease course in patients with tubulointerstitial nephritis and uveitis (TINU) syndrome, focusing on long‐term outcome and the incidence of complications such as chronic kidney disease (CKD).
Jytte Hendrikse, Anne Sina Paula Simon, Viera Kalinina Ayuso, Joke Helena de Boer, Gerrit van den Berg   +4 more
wiley   +1 more source

Acute rheumatic fever in the UK and Ireland: a BPSU surveillance study. [PDF]

Arch Dis Child
Gourlay-Gudex M, Salama M, Crane R, Whittaker E, Parks T.   +4 more
europepmc   +1 more source

Paracetamol prescribing to small animals by veterinarians in Australia and New Zealand

Australian Veterinary Journal, Volume 104, Issue 6, Page 327-333, June 2026.
Objective To describe the prescribing patterns of paracetamol by veterinarians in Australia and New Zealand. Methods An online survey was created and distributed to veterinarians in Australia and New Zealand over a 3‐month period (July–October 2024).
A Tse, W Chee, CJ Boyd, CR Sharp
wiley   +1 more source

Trends in incident acute rheumatic fever or rheumatic heart disease in Indigenous youth in Western Australia: a retrospective cohort study. [PDF]

BMJ Open
MacDonald B, Sodhi-Berry N, Stacey I, Robinson M, Carapetis J, Bowen AC, Budgeon C, Nedkoff L, Katzenellenbogen JM.   +8 more
europepmc   +1 more source

Pyrexia in juvenile dogs: a retrospective analysis of diagnosis and clinical features of 115 Australian cases

Australian Veterinary Journal, Volume 104, Issue 6, Page 356-364, June 2026.
Pyrexia is a non‐specific clinical sign associated with many diseases in dogs. This case series examines the final diagnoses, breed distribution and outcomes in dogs aged 18 months or under with pyrexia >24 h duration. Medical record databases of 11 Australian emergency and referral hospitals between 1st January 2020 and 31st January 2025 were searched
H Lobegeier, J Campo, C Cannon, P Bennett   +3 more
wiley   +1 more source

Immune endotypes in tuberculosis: Keys to decoding disease complexity

Journal of Internal Medicine, Volume 299, Issue 6, Page 670-693, June 2026.
Abstract Tuberculosis (TB) remains a major global health challenge, with multi‐drug antibiotic regimens as the current standard of care. While effective at killing Mycobacterium tuberculosis, these treatments do not resolve persistent inflammation, prevent lung damage, or reverse immune dysregulation that contribute to poor outcomes and disease ...
Shamila D. Alipoor, Julia Guthrie, Lina Davies Forsman, Andrew R. Di Nardo, Susanna Brighenti   +4 more
wiley   +1 more source